冠状动脉疾病和慢性阻塞性肺病患者的重血管化策略
Matthew Brandorff1, Julia Graham1, Kirana Gudi2
1Division of Pulmonary and Critical Care Medicine, New York Presbyterian-Weill Cornell Campus, New York, NY USA.
Current treatment options in cardiovascular medicine
|June 26, 2023
概括
慢性阻塞性肺病 (COPD) 显著增加了冠状动脉疾病 (CAD) 患者接受再血管化的风险. 最佳策略尚不清楚,需要进一步研究风险评估和治疗方法.
科学领域:
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 医学研究 医学研究
背景情况:
- 慢性阻塞性肺病 (COPD) 是冠状动脉疾病 (CAD) 患者不良后果的独立风险因素.
- 在患有CAD和COPD的患者中,重血管化程序具有重大风险.
- 现有文献强调需要更好的风险分层和治疗策略.
研究的目的:
- 审查最近关于COPD对经过再血管化治疗的CAD患者的影响的文献.
- 确定这个患者群体是否存在最佳的复血管化策略.
- 探索这些患者的替代风险评估方式.
主要方法:
- 最近研究的文献综述.
- 分析临床试验数据,包括SYNTAXES试验.
- 评估当前的风险分层工具,如肺功能测试 (PFTs).
主要成果:
- 证实COPD是重复血管化后不良结果的关键独立风险因素.
- 目前还没有确定的最佳再血管化策略.
- 在SYNTAXES试验中,一个不显著的趋势表明了穿皮冠状动脉干预 (PCI) 的潜在短期益处.
- 肺功能测试 (PFT) 在风险评估方面存在局限性;生物标志物研究正在进行中.
结论:
- 慢性肺炎显著增加了接受再血管化的CAD患者的风险.
- 需要进一步的研究来确定最佳的重血管化策略.
- 新的生物标志物可以为这个脆弱的患者群体提供更好的风险评估.
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K
Coronary Artery Disease V: Interprofessional Care
11
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
11
Acute Coronary Syndrome V: Nursing Management
18
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
18
Chronic Obstructive Pulmonary Disease-V: Nursing Management
4.0K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
4.0K
Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
COPD: Management Using Bronchodilators and Corticosteroids
255
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
255


